BOLD - Company ID 0001782303
The table below shows Boundless Bio, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $20.21M | $17.48M | $14.98M | $14.70M | $15.12M | $40.21M |
| Short-term investments | $52.41M | $75.36M | $102.59M | $112.45M | $123.14M | $126.92M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $73.65M |
| $94.62M |
| $120.16M |
| $129.69M |
| $140.36M |
| $170.45M |
| Property, plant & equipment | $97.00K | $2.94M | $3.50M | $3.79M | $4.08M | $3.96M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $73.74M | $140.97M | $168.72M | $179.45M | $191.24M | $175.09M |
| Accounts payable | $1.05M | $2.04M | $1.14M | $2.29M | $1.37M | $2.54M |
| Total current liabilities | $7.77M | $9.58M | $11.85M | $9.21M | $6.34M | $10.01M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $7.77M | $54.59M | $58.55M | $56.76M | $54.65M | - |
| Retained earnings | -$296.92M | -$273.22M | -$246.78M | -$232.91M | -$217.23M | -$185.02M |
| Total equity | $65.98M | $86.38M | $110.17M | $122.69M | $136.59M | $165.08M |